Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and BTB domain-containing protein 8B (ZBTB8B) is a nuclear, DNA-binding transcription factor characterized by the presence of both zinc finger and BTB/POZ domains, which enable it to regulate gene expression, likely through interaction with DNA and other proteins[5][6]. It is highly enriched and functions in early lens development in the mouse, indicating a regulatory role in lens morphogenesis[1]. As a member of the ZBTB family, it may play roles in differentiation and tissue-specific regulation of gene expression, though its precise physiological and pathological roles in humans remain incompletely characterized[1][5][7]. There is no current evidence that it acts as a direct therapeutic target, nor are there any known drugs or specific biomarkers related to ZBTB8B[5]. Its expression has shown associations with some disease phenotypes and cancer, but mechanistic details and clinical applications remain to be elucidated[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain-containing protein 8B (ZBTB8B).